Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
alisporivir (DEB025, Debio 025)
print preview
bookmark
share with colleague
General Information
Company
Debiopharm Group
Description
Oligopeptide cyclophilin inhibitor
Molecular Target
Cyclophilin
Mechanism of Action
Cyclophilin inhibitor
Latest Stage of Development
Phase III
Indication
Hepatitis C virus (HCV)
Partner
Novartis AG
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy
General Information